FDA drug safety communication: FDA warns about several safety issues with opioid pain medicines; requires label changes

Company Name

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum porta libero erat. Nullam at ipsum quis felis egestas vulputate nec nec ligula.

March 24, 2016

tony w

FDA What’s New: Drugs